Provides that every policy which provides coverage for hospital, surgical or medical care or provides reimbursement for laboratory tests or diagnostic X-rays shall provide coverage for testing of familial dysautonomia, Canavan's disease and Tay-Sachs; provides that in order to maintain the confidentiality of persons tested, receipt of acknowledgement from the testing facility shall be deemed sufficient evidence of testing.
- Chamber
- Senate
- Introduced
- Mar 14, 2025
- Last action
- Jan 7, 2026 — REFERRED TO INSURANCE
- Session
- 2025-2026
- Momentum
- 27 · Low